Literature DB >> 11548185

Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections.

G D Georgeson1, B J Szony, K Streitman, A Kovács, L Kovács, A László.   

Abstract

UNLABELLED: We investigated natural killer (NK) cell cytotoxicity in healthy preterm and full-term newborns in comparison to adults, to elucidate the possible role of delivery mode in influencing the NK activity and to evaluate the NK activity in severe neonatal pathological conditions such as bacterial sepsis and recurrent infections. NK cell cytotoxicity was investigated using a 4 h 51Cr release assay with K562 cells as targets expressed as percentage kill in the following study groups: full-term normal spontaneous vaginal delivery (n = 55), full-term caesarean section (n = 51), preterm normal spontaneous vaginal delivery (n = 34), preterm caesarean section (n = 28), bacterial sepsis (n = 15), recurrent neonatal infections (n = 8) and healthy adults aged between 22-42 years (n = 89). NK activity for the normal newborns was determined in paired cord and 2-4 day-old neonate blood. The NK cell cytotoxicity in healthy newborns was significantly lower than in adults (P < 0.01). Prematurity was associated with a significant decrease in NK cell activity compared to full-term neonates (P < 0.05). The mode of delivery did not influence the NK cytotoxicity. In sepsis and recurrent infections, a dramatic decrease in NK cell cytotoxicity was seen related to healthy newborns (P < 0.01).
CONCLUSION: Natural killer cell cytotoxicity is deficient in both neonatal sepsis and recurrent infections.

Entities:  

Mesh:

Year:  2001        PMID: 11548185     DOI: 10.1007/s004310100773

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

Review 1.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

2.  A randomized placebo-controlled trial of massage therapy on the immune system of preterm infants.

Authors:  Jocelyn Y Ang; Jorge L Lua; Ambika Mathur; Ronald Thomas; Basim I Asmar; Sureyya Savasan; Steven Buck; Michael Long; Seetha Shankaran
Journal:  Pediatrics       Date:  2012-11-12       Impact factor: 7.124

Review 3.  Pathophysiology and treatment of septic shock in neonates.

Authors:  James L Wynn; Hector R Wong
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 4.  The biology of natural killer cells during sepsis.

Authors:  Yin Guo; Naeem K Patil; Liming Luan; Julia K Bohannon; Edward R Sherwood
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

Review 5.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

Review 6.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.

Authors:  Michael R Verneris; Jeffrey S Miller
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

Review 7.  Natural killer cells in lung transplantation.

Authors:  Daniel R Calabrese; Lewis L Lanier; John R Greenland
Journal:  Thorax       Date:  2018-10-31       Impact factor: 9.139

8.  A case of Listeria monocytogenes endophthalmitis with recurrent inflammation and novel management.

Authors:  Adam C Weber; Ashleigh L Levison; Sunil K Srivastava; Careen Y Lowder
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-10-05

9.  Toll-like receptors expression and interferon-γ production by NK cells in human sepsis.

Authors:  Fernando Souza-Fonseca-Guimaraes; Marianna Parlato; François Philippart; Benoît Misset; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2012-10-25       Impact factor: 9.097

10.  NK cell compartment in patients with coronary heart disease.

Authors:  Łukasz Hak; Jolanta Myśliwska; Joanna Więckiewicz; Krzysztof Szyndler; Piotr Trzonkowski; Janusz Siebert; Andrzej Myśliwski
Journal:  Immun Ageing       Date:  2007-05-08       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.